CCPortal
DOI10.1172/JCI67580
Induction of myelodysplasia by myeloid-derived suppressor cells
Chen, Xianghong; Eksioglu, Erika A.; Zhou, Junmin; Zhang, Ling; Djeu, Julie; Fortenbery, Nicole; Epling-Burnette, Pearlie; Van Bijnen, Sandra; Dolstra, Harry; Cannon, John; Youn, Je-in; Donatelli, Sarah S.; Qin, Dahui; De Witte, Theo; Tao, Jianguo; Wang, Huaquan; Cheng, Pingyan; Gabrilovich, Dmitry I.; List, Alan; Wei, Sheng
发表日期2013
ISSN0021-9738
起始页码4595
结束页码4611
卷号123期号:11
英文摘要Myelodysplastic syndromes (MDS) are age-dependent stem cell malignancies that share biological features of activated adaptive immune response and ineffective hematopoiesis. Here we report that myeloid-derived suppressor cells (MDSC), which are classically linked to immunosuppression, inflammation, and cancer, were markedly expanded in the bone marrow of MDS patients and played a pathogenetic role in the development of ineffective hematopoiesis. These clonally distinct MDSC overproduce hematopoietic suppressive cytokines and function as potent apoptotic effectors targeting autologous hematopoietic progenitors. Using multiple transfected cell models, we found that MDSC expansion is driven by the interaction of the proinflammatory molecule S100A9 with CD33. These 2 proteins formed a functional ligand/receptor pair that recruited components to CD33's inununoreceptor tyrosine-based inhibition motif (ITIM), inducing secretion of the suppressive cytokines IL-10 and TGF-beta by immature myeloid cells. S100A9 transgenic mice displayed bone marrow accumulation of MDSC accompanied by development of progressive multilineage cytopenias and cytological dysplasia. Importantly, early forced maturation of MDSC by either all-trans-retinoic acid treatment or active imrnunoreceptor tyrosine-based activation motif-bearing (ITAM-bearing) adapter protein (DAP12) interruption of CD33 signaling rescued the hematologic phenotype. These findings indicate that primary bone marrow expansion of MDSC driven by the S100A9/CD33 pathway perturbs hematopoiesis and contributes to the development of MDS.
WOS研究方向Research & Experimental Medicine
WOS类目Medicine, Research & Experimental
来源期刊JOURNAL OF CLINICAL INVESTIGATION
文献类型期刊论文
条目标识符http://gcip.llas.ac.cn/handle/2XKMVOVA/158609
作者单位Wei, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, MRC 4072,12902 Magnolia Dr, Tampa, FL 33647 USA.
推荐引用方式
GB/T 7714
Chen, Xianghong,Eksioglu, Erika A.,Zhou, Junmin,et al. Induction of myelodysplasia by myeloid-derived suppressor cells[J],2013,123(11).
APA Chen, Xianghong.,Eksioglu, Erika A..,Zhou, Junmin.,Zhang, Ling.,Djeu, Julie.,...&Wei, Sheng.(2013).Induction of myelodysplasia by myeloid-derived suppressor cells.JOURNAL OF CLINICAL INVESTIGATION,123(11).
MLA Chen, Xianghong,et al."Induction of myelodysplasia by myeloid-derived suppressor cells".JOURNAL OF CLINICAL INVESTIGATION 123.11(2013).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chen, Xianghong]的文章
[Eksioglu, Erika A.]的文章
[Zhou, Junmin]的文章
百度学术
百度学术中相似的文章
[Chen, Xianghong]的文章
[Eksioglu, Erika A.]的文章
[Zhou, Junmin]的文章
必应学术
必应学术中相似的文章
[Chen, Xianghong]的文章
[Eksioglu, Erika A.]的文章
[Zhou, Junmin]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。